FluidForm Bio
Erik Waters is the Co-Founder of Persistently, where Erik works on aligning and accelerating company execution, culture, and strategy. Erik is also the Chief Financial Officer for FluidForm, a company focused on 3D bioprinting technology for building human tissue. Previously, Erik served as the Managing Partner at Davis Square Group, where Erik successfully acquired Adtech Systems. With a background in finance and strategy, Erik has held roles such as Vice President at GreatPoint Energy, Director of Finance at Cerberus Capital Management, and Small Business Consultant at Chicago Community Ventures. Erik holds an MBA from The University of Chicago Booth School of Business and a B.A. in Economics from Colby College.
This person is not in any teams
FluidForm Bio
FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to produce the highest quality tissue in a variety of applications. We deliver human tissue that is indistinguishable from the real thing by integrating breakthrough innovations in 3D printing, computational and synthetic biology, AI, and advanced materials science. Our living tissue will offer therapies to countless patients who deserve better treatment options.